Form 4 for MXCT MAXCYTE, INC.
Accepted 2023-03-30 00:00:00 ET · period of report 2023-03-29 · accession 0001209191-23-021573 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-30 | 2023-03-29 | MXCT | DOUGLAS RICHARD | Dir | P - Purchase | $4.32 | +80.0K | 100.0K | +400% | +$345.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-29 | P | A | 80,000 | $4.32 | 100,000 | D | — | — | (F1) The Reporting Person purchased the securities on the open market at purchase prices ranging from $4.20 to $4.35 per share, with a weighted average purchase price of $4.3185 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price. |